P04.5 Newborn affected by maternal use of nutritional chemical substances
Billable / valid for submission ICD10CM Release FY2026
Short description: Newborn aff by maternal use of nutritional chemical substnc
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| FY2026 | 2025-10-01 | current | Newborn affected by maternal use of nutritional chemical substances | yes |
Related codes in P04
- P04 Newborn affected by noxious substances transmitted via placenta or breast milk
- P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
- P04.1 Newborn affected by other maternal medication
- P04.11 Newborn affected by maternal antineoplastic chemotherapy
- P04.12 Newborn affected by maternal cytotoxic drugs
- P04.13 Newborn affected by maternal use of anticonvulsants
- P04.14 Newborn affected by maternal use of opiates
- P04.15 Newborn affected by maternal use of antidepressants
- P04.16 Newborn affected by maternal use of amphetamines
- P04.17 Newborn affected by maternal use of sedative-hypnotics
- P04.18 Newborn affected by other maternal medication
- P04.19 Newborn affected by maternal use of unspecified medication
- P04.1A Newborn affected by maternal use of anxiolytics
- P04.2 Newborn affected by maternal use of tobacco
- P04.3 Newborn affected by maternal use of alcohol
- P04.4 Newborn affected by maternal use of drugs of addiction
- P04.40 Newborn affected by maternal use of unspecified drugs of addiction
- P04.41 Newborn affected by maternal use of cocaine
- P04.42 Newborn affected by maternal use of hallucinogens
- P04.49 Newborn affected by maternal use of other drugs of addiction